Get started
Author

Haoyang Mu

Observed name: Mu, Haoyang
ORCID: 0009-0006-1909-2429
Observed ORCID: 0009-0006-1909-2429
OpenAlex ID: A5140531103
Analysis and figure-generation code for cross-disease evaluation of atopic dermatitis-derived transcriptomic scores
2026 · Mu, Haoyang · Zenodo (CERN European Organization for Nuclear Research)
Supporting data and code for: Network-toxicology annotation adds hits but no detectable specificity to single-instrument eQTL Mendelian randomization: a genome-wide colocalisation audit in acne
2026 · Mu, Haoyang, Jin, Shan, et al. · Zenodo (CERN European Organization for Nuclear Research)
ATOMIC locked validation audit: audit outputs and partial reproduction materials
2026 · Mu, Haoyang, Jin, Shan, et al. · Zenodo (CERN European Organization for Nuclear Research)
Alopecia areata scalp transcriptomics: score-level data, results, figures, and code for lesional, nonlesional, and healthy comparisons
2026 · Mu, Haoyang, Jin, Shan, et al. · Zenodo (CERN European Organization for Nuclear Research)
Source data and analysis code for: A pre-registered reanalysis quantifies placebo-controlled change in a fixed skin gene-set score (SKITm17) during dupilumab treatment of atopic dermatitis
2026 · Mu, Haoyang, Jin, Shan, et al. · Zenodo (CERN European Organization for Nuclear Research)
Supplementary Reproducibility Archive: Cross-cohort transportability of an IL4R–CCL17–TSLP lesional transcriptomic signal in psoriasis (v1.0)
2026 · Mu, Haoyang, Jin, Shan, et al. · Zenodo (CERN European Organization for Nuclear Research)
Result-blind framework development and prospective evaluation of treatment-strategy identifiability after response/control in atopic dermatitis (operative prospective registration)
2026 · Haoyang Mu
Patient-Level Keratinocyte State Programs in Atopic Dermatitis: Prospective Registration Before Disease-Effect Testing
2026 · Haoyang Mu
Predefined type-2, epidermal-barrier, and atopic-dermatitis molecular programs during treatment: a placebo-controlled longitudinal test with independent cross-treatment directional confirmation
2026 · Haoyang Mu
AD lesion-state disulfidptosis-related score validation
2026 · Mu, Haoyang, Jin, Shan · Zenodo (CERN European Organization for Nuclear Research)
Donor-aware secondary reanalysis of GSE278330 psoriasis single-cell data
2026 · Mu, Haoyang, Jin, Shan, et al. · Zenodo (CERN European Organization for Nuclear Research)
AD lesion-state disulfidptosis-related score validation: reproducibility release
2026 · Mu, Haoyang, Jin, Shan · Zenodo (CERN European Organization for Nuclear Research)
Genetic Tractability of Clinically Relevant Dermatologic Immune Pathway Genes: A Tissue-Aware cis-eQTL Mendelian Randomization Screen
2026 · Mu, Haoyang, Jin, Shan · Zenodo (CERN European Organization for Nuclear Research)
Works count: 13
Citation count:
H-index:
I10-index:
Year
Topic
Type